Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03656822 · ClinicalTrials.gov registry record
Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 303
- Enrollment target
NCT03656822: Completed study, sponsored by NYU Langone Health.
NCT03656822 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 303 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03656822 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 303 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether adding new methods of data visualization to routine clinical care will improve (i) surgical planning and (ii) surgical outcomes in patients with kidney and prostate tumors.
Primary Outcome
measure of the amount of time it takes surgeon to remove tumor
Interventions
- DIAGNOSTIC_TEST Routine CT
- DIAGNOSTIC_TEST Routine imaging CT with a 3D printed model
- DIAGNOSTIC_TEST Routine imaging MRI with a 3D printed model
- DIAGNOSTIC_TEST Routine MRI
- DIAGNOSTIC_TEST Routine imaging CT with a VR model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2019-12-31 |
What the finished NCT03656822 record still lists
NCT03656822 is an observational study that tracks outcomes without assigning an intervention. The registered 303 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Routine CT is the first listed.
NCT03656822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03656822 about?
NCT03656822 is a clinical study titled "Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models". The purpose of this study is to determine whether adding new methods of data visualization to routine clinical care will improve (i) surgical planning and (ii) surgical outcomes in patients with kidney and prostate tumors.
What is the current status of trial NCT03656822?
This trial is currently completed. The enrollment target is 303 participants. The study started on 2017-02-07. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03656822?
The interventions under investigation include: Routine CT (DIAGNOSTIC_TEST), Routine imaging CT with a 3D printed model (DIAGNOSTIC_TEST), Routine imaging MRI with a 3D printed model (DIAGNOSTIC_TEST), Routine MRI (DIAGNOSTIC_TEST), Routine imaging CT with a VR model (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03656822?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI